Nuzenio Source-attributed brief

Honasa Consumer to acquire 58% stake in Fluence Pharma

In a BSE filing, the company said it will acquire a majority stake via secondary purchase at about ₹135 crores enterprise value and will acquire the remaining 42% in two tranches over the next 5-7 years

The Hindu BusinessLine·
AI summary

In a BSE filing, the company said it will acquire a majority stake via secondary purchase at about ₹135 crores enterprise value and will acquire the remaining 42% in two tranches over the next 5-7 years

What happened

In a BSE filing, the company said it will acquire a majority stake via secondary purchase at about ₹135 crores enterprise value and will acquire the remaining 42% in two tranches over the next 5-7 years

Why it matters

This business report is being tracked from The Hindu BusinessLine because it may affect readers, markets, policy, culture, or daily decisions.

Key facts
  • Category: business
  • Edition: IN
  • Fetched: Wed, 24 Jun 2026 04:41:24 GMT
Read original publisher story Open live Nuzenio coverage Source attribution

Nuzenio shows copyright-safe summaries and context. Full reporting stays with the original publisher.